|
|
|
|
|
|
|
|
|
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
|
||
|
|
||
|
Cancer Pipeline • CTK110 • CTK-100144 • CTK-000147 • Discovery Compounds/10+ Targets Discovery Compounds/10+ Targets In addition to its advanced aurora kinase, Hsp90, and proteasome projects, Cetek is currently engaged in several additional anti-cancer initiatives involving attractive, well-validated targets. The stage of these discovery projects varies between assay development, screening, and lead isolation. Overall, Cetek’s internal drug discovery effort capitalizes on the strength of its integrated technologies and is producing a pipeline of promising drug candidates.
|
Cetek Corporation • 508-229-8900 • info@cetek.com Home | About Cetek
| Proprietary
Drug Discovery Technologies | Cancer Drugs & Pipeline
©1998-2006 Cetek Corporation, Marlborough, MA,
USA. |
